Uncategorized
Studies support targeting IOP
Results from randomized controlled clinical trials investigating populations covering the spectrum
from ocular hypertension to advanced glaucoma provide clear evidence that for most patients, glaucoma is an
IOP-sensitive optic neuropathy for which lowering IOP is effective in slowing or arresting
progression.